Page 4 - Accessed May News Today

A lipoprotein (a) (Lp[a]) assay has been granted breakthrough device designation to expand identification of patients with elevated Lp(a) and genetic predispositions to cardiovascular disease.

A1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

The FDA has granted orphan drug designation to azeliragon as a potential therapeutic option for patients with pancreatic cancer.

Professor Susan Cleary argues that the NHI is a wide-ranging reform with both positive and controversial aspects. The key will be to find a middle ground in order to continue the journey to universal health coverage.

FDA has given accelerated approval for lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed or refractory (R/R) follicular lymphoma.

The Karnataka state government passed the Licensing and Regulation of Protests, Demonstrations and Protest Marches (Bengaluru City) order 2021 in January 2022

Mathematics is the Language of Science

Poster aims to improve awareness of the potential risk of suicidal ideation in patients taking semaglutide.

A new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.

New research on tardive dyskinesia has also been featured at the 2024 APA Annual Meeting.